{"entity":{"id":"nct07736495","kind":"trial","name":"Protective Role of Alpha-Lipoic Acid in Chemotherapy-Induced Mucositis","aka":[],"tldr":"A phase 2/3 trial in colorectal cancer, run by Ain Shams University, now recruiting.","summary":"Protective Role of Alpha-Lipoic Acid in Chemotherapy-Induced Mucositis is a phase 2/3, randomised interventional study registered as NCT07736495 by Ain Shams University, with a registry enrolment figure of 50 participants, started 2026-07-27 and due to reach its primary completion in 2026-12-27. Interventions recorded: alpha lipoic acid 600 mg twice daily; Placebo Tablet. Conditions listed: Colorectal Cancer. Primary outcome: Serum levels of malondialdehyde (MDA). Sites: Egypt. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT07736495","url":"https://clinicaltrials.gov/study/NCT07736495"}],"tags":["ctgov-ingest","colorectal-deep-dive"],"related":[],"cancers":["rectal-cancer","colon-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07736495","phase":"2/3","setting":"Evaluation of the Protective Effect of Alpha-Lipoic Acid Against 5-Fluorouracil-Induced Oral Mucositis in Colorectal Cancer Patients","sponsor":"Ain Shams University","enrolled":50,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07736495/","neighbours":{"cancer":[{"id":"colon-cancer","kind":"cancer","name":"Colon cancer (adenocarcinoma of the colon)","route":"/cancers/colon-cancer/"},{"id":"rectal-cancer","kind":"cancer","name":"Rectal cancer","route":"/cancers/rectal-cancer/"}],"term":[{"id":"colorectal-trials-open-today","kind":"term","name":"Colorectal cancer trials open today (registry snapshot)","route":"/terms/colorectal-trials-open-today/"}]}}